Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Gastrointestinal Oncology|May 20, 2021
Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysisChristina X Chamberlain, Elizabeth Faust, Debbie Goldschmidt, et al.Clinical Therapeutics|June 27, 2015
Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United StatesT Kim Le, Dendy Macaulay, Anupama Kalsekar, et al.The Journal of Rheumatology|February 17, 2019
Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United StatesZhou Zhou, Yanni Fan, Wenxi Tang, et al.Acta Ophthalmologica|March 3, 2016
Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitisJennifer E Thorne, Martha Skup, Namita Tundia, et al.Respiratory Medicine|June 29, 2013
Development and validation of a claims-based prediction model for COPD severityDendy Macaulay, Shawn X Sun, Rachael A Sorg, et al.Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 29, 2015
Impact of a Telehealth and Care Management Program on All-Cause Mortality and Healthcare Utilization in Patients with Heart FailureDavid P Kao, JoAnn Lindenfeld, Dendy Macaulay, et al.Hematology (Amsterdam, Netherlands)|December 14, 2023
Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiencyErin Zagadailov, Hanny Al-Samkari, Audra N Boscoe, et al.Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevirT Kim Le, Anupama Kalsekar, Dendy Macaulay, et al.Journal of Medical Economics|July 5, 2016
Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn's disease in Argentina, Brazil, Colombia, and MexicoNamita Tundia, Paulo Gustavo Kotze, Jorge Rojas Serrano, et al.Pageof 3